Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial
Title:
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial
Author:
Launay, Odile Sadorge, Christine Jolly, Nathalie Poirier, Béatrice Béchet, Stéphane van der Vliet, Diane Seffer, Valérie Fenner, Nicola Dowling, Kelly Giemza, Raphaela Johnson, Julie Ndiaye, Anna Vray, Muriel Sansonetti, Philippe Morand, Philippe Poyart, Claire Lewis, David Gougeon, Marie-Lise